NDC 50090-0139-04 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0139
- Requested NDC
- 50090-0139-04
- Package NDCs from labels
- 50090-0139-4, 50090-0139-1, 50090-0139-3, 50090-0139-0, 50090-0139-2, 50090-0139-04
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydralazine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2025-12-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0139-0 | Hydralazine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0139-1 | Hydralazine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0139-2 | Hydralazine Hydrochloride | 180 in 1 BOTTLE | TABLET | 180 | 31 | |
| 50090-0139-3 | Hydralazine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 31 | |
| 50090-0139-4 | Hydralazine Hydrochloride | 270 in 1 BOTTLE | TABLET | 270 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0139 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 27 | Current NDC, Legacy NDC, 5 package rows | 20230623_f16f1d87-f9e6-4555-9baf-26ff17cb1d28.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0139-1 | EA - Each | 50090-0139 | 909665fd-356e-4420-8e10-37dd14f0f8e2 | 1 | 2021-05-05 |
| 50090-0139-2 | EA - Each | 50090-0139 | 504f769f-0c65-482e-baf1-0ffe9f65ff64 | 1 | 2021-05-05 |
| 50090-0139-3 | EA - Each | 50090-0139 | 60697e64-520d-4838-9848-a18d3df45535 | 1 | 2021-05-05 |
| 50090-0139-4 | EA - Each | 50090-0139 | 8460a52a-9377-4614-aab4-ed33eb38415c | 1 | 2021-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE | ACTIVE INGREDIENT | FD171B778Y | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| HYDRALAZINE | ACTIVE MOIETY | 26NAK24LS8 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Navinta LLC | ae5d85df-11a3-4952-ade2-596d57cdd987 | 2026-04-21 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 669532c9-ba15-4f4b-95a8-13782deb3521 | 2026-04-03 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Safecor Health, LLC | 66c5eaa4-a51a-464b-98ad-f094f32876dd | 2026-03-11 | Warnings, Adverse reactions | 905225 905199 905395 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | f3c806a4-b971-421c-bcb9-9979c6d7aaec | 2026-02-27 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 4aa1b3e8-9389-fe2c-e063-6294a90a7fb9 | 2026-02-12 | Warnings, Adverse reactions | 905225 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | REMEDYREPACK INC. | 89afc8ef-27c4-489a-81de-3f8f65f6bbb8 | 2026-02-09 | Warnings, Adverse reactions | ANDA040901 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Strides Pharma Science Limited | b3d1786d-c3ff-42f1-a09f-37a9c9021e5a | 2026-02-02 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e9450e82-329f-4fd8-a0b3-3e8e22715965 | 2026-01-07 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | bf1b7c2f-535c-45bb-928a-65606d87685e | 2025-12-16 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Chartwell RX, LLC | 0c7f9bd0-6c0a-4521-b77a-3582faa96874 | 2025-12-10 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | 7253aaa0-e272-499f-9bfa-304e9556a8fb | 2025-12-05 | Warnings, Adverse reactions | ANDA040901 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | f16f1d87-f9e6-4555-9baf-26ff17cb1d28 | 2025-12-05 | Warnings, Adverse reactions | ANDA040901 50090-0139-4 50090-0139-0 50090-0139-3 50090-0137-0 50090-0139-2 50090-0137-5 50090-0137-2 50090-0139-1 50090-0137-4 50090-0137 50090-0139 50090013904 905225 905395 d14a312f-cf30-4282-8387-ac085046255b f16f1d87-f9e6-4555-9baf-26ff17cb1d28 FD171B778Y |
| BiDil | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | Azurity Pharmaceuticals, Inc. | e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00 | 2025-11-30 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f34904dc-c945-4de4-8594-34e4f4ac1983 | 2025-11-28 | Warnings, Adverse reactions | FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Eugia US LLC | e08d8b6c-a184-4dd5-84ef-bac90e4b1c33 | 2025-11-11 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 41c019e3-7b07-5f12-e063-6294a90a5365 | 2025-10-22 | Warnings, Adverse reactions | 905199 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 3f8fb1fc-ffef-4f94-e063-6294a90a2b82 | 2025-09-24 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 493a8b7e-5bb1-4db2-91a7-77ed87864131 | 2025-07-22 | Warnings, Adverse reactions | 905225 905199 905395 FD171B778Y |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ProPharma Distribution | 3855c3da-ff25-8301-e063-6294a90a22b3 | 2025-07-18 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 024ac6b8-5ce0-4435-9b11-b1806c511d7b | 2025-07-01 | Warnings, Adverse reactions | 905225 FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.